Back to search

Article

CK1α agonists attenuate medulloblastoma stemness and relapse risk

2025-11-11

Abstract excerpt

<title>Abstract</title> <p> While outcomes for most children with medulloblastoma (MB) are relatively favorable, those in the Sonic Hedgehog (SHH) subgroup with <italic>Tumor Protein P53</italic> ( <italic>TP53</italic> ) mutations–known as the SHHα subtype–face a much poorer prognosis. SHHα patients relapse more frequently and rapidly, underscoring the need for therapies that prevent recurrence. We recently...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
09a52dcc-8714-5b4e-91d0-8c0b267e4e2f
DOI
10.21203/rs.3.rs-7915551/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CK1α agonists attenuate medulloblastoma stemness and relapse riskDOI 10.21203/rs.3.rs-7915551/v1
Select a neighboring publication to make it the new centre.